Tuberculosis
Researchers from the United States describe findings in tuberculosis studies
Published in Tuberculosis Week, September 18th, 2006
Study 1: Adherence to latent tuberculosis infection therapy among Latino immigrants declines after between 2 and 9 months.
"One third of the world population is infected with Mycobacterium tuberculosis. In the United States, a key component for eliminating tuberculosis (TB) is treating latent TB infection (LTBI) in high-risk persons such as immigrants," researchers in the United States report.
R.L. Ailinger and colleagues at George Mason University in Fairfax conducted a study to examine "the prevalence of adherence to LTBI therapy and the influence...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Tuberculosis Week
Source: Tuberculosis Week (2006-09-18)
More Articles from Tuberculosis Week
- Mycobacterium Tuberculosis Pathogenesis
IL-12p40 required for dendritic cell migration and T cell priming after tuberculosis infection - Tuberculosis Diagnostics
Interferon-gamma assays superior to tuberculin skin tests - Tuberculosis Diagnostics
Rifampin resistance is a surrogate marker for multidrug-resistant tuberculosis - Tuberculosis Pathophysiology
Active tuberculosis patients have increased anti-CCP and IgM rheumatoid factor titers - Tuberculosis Vaccine
Tuberculin reactivity in BCG-vaccinated populations depends on patient age and TB incidence - Avian Influenza
Analysis of Spanish flu cases suggests serotherapy might help in bird flu pandemic - More from this issue of Tuberculosis Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
